BNT166a not checked

BioNTech

FollowEvery change as it happens, and a Monday email
Stage
 
Next date
Phase 2 trial completes
Trials
1 active
2 in total

What this is

How it works
How it works isn't classified yet
How it’s given
“Intramuscular injection. Injections should be given in the deltoid muscle, using the same non-dominant arm for all IMP doses.”In the company’s words, NCT07379580 on ClinicalTrials.gov
Tested for
Mpox (Monkeypox), Smallpox, Orthopoxvirus Infection
Main trialPhase 2
“This is a randomized, double-blind, placebo-controlled study which aims to assess the safety, reactogenicity, and immunogenicity after one and two doses of BNT166a or placebo in healthy participants.”In the company’s words, NCT07379580 on ClinicalTrials.gov

Other drugs for Smallpox

All 3 drugs for Smallpox

Coming up1

Changes0

Last 90 days

No changes yet. We started recording changes on 6 Nov 2026.

Trials2

TrialPhaseCompletesWhat it tests
Phase 2Recruiting Jun 2027 A Randomized Clinical Trial Investigating the Safety, Reactogenicity, and Immunogenicity After Immunization With an mRNA-based Mpox Vaccine Candidate in Africa
Phase 1/2Completed 25 Aug 2025 A Clinical Study Investigating the Safety and Immune Responses After Immunization With Investigational Monkeypox Vaccines
A trial in both registries shows both numbers.

About

Sources
ClinicalTrials.gov updated 18 Nov 2026 · EU trials register (CTIS) updated 18 Nov 2026 · openFDA updated 17 Nov 2026

Follow BNT166a

Following is part of Solo: you see every change to BNT166a the day it happens.

Solo

$49a month, excl. VAT

  • Follow up to 5 landscapes, companies or drugs
  • Every change, the day it happens
  • A Monday email with the week’s changes
Choose Solo

Free

$0no card

  • One landscape of your own, in full
  • The top 10 of everything else
Sign up free

Have an account? Sign in